Cell-free DNA in maternal blood and artificial intelligence: accurate prenatal detection of fetal congenital heart defects
Open Access
- 7 August 2022
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 228 (1) , 76.e1-76.e10
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Causal analysis approaches in Ingenuity Pathway AnalysisBioinformatics, 2013
- Barriers to prenatal detection of congenital heart disease: a population‐based studyUltrasound in Obstetrics & Gynecology, 2012
- Epigenetic mechanisms in cardiac development and diseaseActa Biochimica et Biophysica Sinica, 2012
- Birth Prevalence of Congenital Heart Disease WorldwideJACC, 2011
- Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblastPrenatal Diagnosis, 2007
- Trophoblastic Oxidative Stress and the Release of Cell-Free Feto-Placental DNAThe American Journal of Pathology, 2006
- Elevated first-trimester nuchal translucency increases the risk of congenital heart defectsAmerican Journal of Obstetrics and Gynecology, 2005
- Persistent elevation of cell-free fetal DNA levels in maternal plasma after selective laser coagulation of chorionic plate anastomoses in severe midgestational twin-twin transfusion syndromeAmerican Journal of Obstetrics and Gynecology, 2005
- Detection of Fetal DNA and RNA in Placenta-Derived Syncytiotrophoblast Microparticles Generated in VitroClinical Chemistry, 2004
- Reducing false negatives in clinical practice: The role of neural network technologyAmerican Journal of Obstetrics and Gynecology, 1996